期刊文献+

玉竹中高异黄酮类化合物生物活性研究 被引量:8

Studies on Biological Activity of Homoisoflavanones from Polygonatum odoratum(Mill.) Druce
下载PDF
导出
摘要 采用四唑盐(MTT)比色法、白细胞弹性蛋白酶抑制剂筛选模型及二氢乳清酸脱氢酶抑制剂筛选模型对从玉竹中分离出的4个高异黄酮类化合物进行生物活性评价,探讨化合物结构与其活性之间的构效关系.高异黄酮类化合物1~4对肿瘤细胞K562,A549和HCT-15具有细胞毒性,IC50为7~35μg/mL;化合物1~4对人白细胞弹性蛋白酶有抑制作用,IC50分别为13.1,70.4,13.8,55.2μg/mL;化合物2,4对二氢乳清酸脱氢酶有一定的抑制作用,IC50分别为10.0,11.1μg/mL.高异黄酮类化合物的生物活性与其取代基的类型及位置有关. MTT assays were used to explore the inhibiting effect of the homoisoflavanones on cancer cell.Two high throughput screening modeles were established,one for screening human leukocyte elastase(HLE) inhibitor and the other for dihydroorotate dehydrogenase(DHODH) inhibitor from nature product.Compound 1~4 showed inhibitory activity on K562,A549 and HCT-15 cancer cell with IC50 from 7 to 35 μg/mL.Compound 1~4 showed inhibitory activity against HLE with IC50 of 13.1,70.4,13.8,55.2 μg/mL,respectively.Compound 2 and 4 showed inhibitory activity against DHODH with IC50 10.0,11.1 μg/mL,respectively.The location and type of substituent group affect biological activity of homoisoflavanones.
出处 《河北师范大学学报(自然科学版)》 CAS 北大核心 2012年第5期509-511,共3页 Journal of Hebei Normal University:Natural Science
基金 国家重大新药创制专项(2010ZX09401-403)
关键词 玉竹 高异黄酮类化合物 抗肿瘤活性 人白细胞弹性蛋白酶 二氢乳清酸脱氢酶 Polygonatum odoratum homoisoflavanones anti-tumor activity human leukocyte elastase dihydroorotate dehydrogenase
  • 相关文献

参考文献10

二级参考文献51

  • 1任晓,郑智慧,路新华,董悦生,林洁,马瑛,刘梅,张华,贺建功.微生物来源的人白细胞弹性蛋白酶抑制剂F01-221A的研究[J].中国抗生素杂志,2006,31(8):458-461. 被引量:4
  • 2江洪波,田祥琴,胡小兵,黄静,孙奇,陈渝.麦冬中几种二氢高异黄酮的立体结构[J].华西药学杂志,2006,21(5):416-419. 被引量:12
  • 3郑秀娟,任学芳,陈刚,陶黎明,熊思东,王缨.新型免疫抑制剂FK520的功能研究[J].现代免疫学,2007,27(1):7-11. 被引量:5
  • 4Tamura G, Suzuki S, Takatsuli A, et al. Ascochlorin, a New Antibiotic, Found by Paper-disc Agar-diffusion Method. The Journal of Antibiotics, 1968, 21:539 - 544.
  • 5Tsuruga M, Nakajima H, Magae J. Immunosuppressive Activity of 4-O-Methylascochlorin. The Journal of Antibiotics, 2007, 60( 1 ) : 20 - 26.
  • 6Jeffrey B, Carolyn HM, Nicholas AM, et al. High- throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. The Journal of Biological Chemistry, 2005, 22:21847 - 21853.
  • 7Dayer JM, Cutolo M. Is there a rationale to using leflunomide in early rheumatoid arthritis. Clinical and Experimental Rheumatology, 2005, 23 : 404 - 409.
  • 8Lou T, Wang C, Chen Z, et al. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy. Nephrology (Carlton), 2006, 11:113- 116.
  • 9Mori K, Takechi S. Synthesis of the natural enantiomers of ascochlorin, ascofuranone and ascofuranol. Tetrahedron, 1985, 41 (15) :3049 - 3062.
  • 10Sasaki H, Hosokawa T, Okutomi T, et al. Ascufuranone, a new antibiotic from Ascochyta viciae. Tetrahedron Letters, 1972 : 2541 - 2544.

共引文献206

同被引文献201

引证文献8

二级引证文献239

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部